|
Our storyWorking in Pharma for decades and establishing our own successful transdermal company which was eventually acquired we realized more can be done to provide innovative products.
So as we sat at the intersection of Greene Street, we realized that we could make a bigger difference in the lives of patients and physicians. We believed that if we leveraged our experience, our connections, and our commitment, we could make a meaningful impact on the health of the average patient…and do our part to help confront the national epidemic of opioid addiction. That’s how Greene Street Pharmaceuticals was born. If you'd like to learn more about us and what we believe in, please give me a call. I'd love to talk with you. |
About Greene Street Pharmaceuticals
We are a privately held pharmaceutical company that, specializes in the formulation, development and scale up of transdermal drug delivery systems including abuse-resistant opioid, generic, OTC and 505(b)2 transdermal delivery systems. Our products once developed, are out-licensed and supported by our company
|
About FrankFrank C. Jones, CEO
Frank has more than 30 years of pharmaceutical experience. He has served in both domestic and international companies, in various executive positions. As co-founder of ProSolus Pharmaceuticals, a transformative transdermal company, Frank helped build the organization and develop lasting and strategic partnerships for numerous transdermal products. After a successful acquisition by Mission Pharmacal in 2015, the initial work at ProSolus continues. As co-founder of Greene Street Pharmaceuticals, Frank continues to capitalize on his extensive experience and find innovative products that make a meaningful difference in the lives of patients and physicians. Degreed in chemistry and biology, Frank remains involved with various Boards in an advisory role. |
|
About BillWilliam Charles Dixon, Legal Counsel
Bill is a lawyer who, for almost 30 years, has focused on business support, entrepreneurial development, and start-ups. He has provided advice in corporate and commercial matters, including litigation management, employment counseling, and strategic planning. He is a co-founder of ProSolus Pharmaceuticals, which focuses on formulating and developing transdermal products. Bill is also a shareholder in and co-founder of SCILEX Pharmaceuticals, another company that focuses on transdermal delivery systems. As co-founder and Legal Counsel to Greene Street Pharmaceuticals, Bill enjoys collaborating on projects that can have an immediate and positive impact on the lives of patients and physicians. He is a member in good standing of the Pennsylvania, New York, and Massachusetts Bars. |